University of Jos Institutional Repository >
Health Sciences >
Medical Laboratory Sciences >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/1688
|
Title: | Sero-Epidemiological Survey of Human Cytomegalo Virus Infection among Expectant Mothers in Bida, Nigeria |
Authors: | Okwori, A. Olabode, A. Emumwen, E. Echeonwu, G. Lugos, M. Okpe, E. Okopi, J. Adetunji, J. |
Issue Date: | 2008 |
Publisher: | The Internet Journal of Infectious Diseases |
Citation: | A Okwori, A Olabode, E Emumwen, G Echeonwu, M Lugos, E Okpe, J Okopi, J Adetunji. Sero-Epidemiological Survey Of Human Cytomegalo Virus Infection Among Expectant Mothers In Bida, Nigeria. The Internet Journal of Infectious Diseases. 2008 Volume 7 Number 1. |
Series/Report no.: | Vol. 7;No. 1; Pp 1-5 |
Abstract: | Human cytomegalovirus (HCMV) is a major public health problem throughout the world. Serological surveys have shown HCMV
infection in virtually every population that have been tested. HCMV is a known cause of congenital defects in babies of infected
mothers. This work was aimed at determining the seroprevalence of HCMV among pregnant women. The prevalence of HCMV
infections among two hundred and fifty three (253) pregnant women attending ante-natal clinic at the Federal Medical Centre,
Bida between the months of November, 2004 and January, 2005 was studied. Serological screening for HCMV antibodies was
done using Immunocomb® 11 IgG and ImmunoLISA TM CMV IgG. Two hundred and thirteen (213) (84.2%) were positive.
Prevalence of HCMV was higher among multigravid women (86.1%) than primigravid women (77.1%). More of the pregnant
women who are non-health workers (84.6%) had CMV antibodies in their sera than health workers (25.0%). There was a
significant association in HCMV seroprevalence (p<.05) between health workers and non – health workers. The prevalence of
HCMV was highest (87.5%) among the Teenage pregnant (TP) women. There were higher seroprevalence of HCMV in second
trimester (ST) (86.2%) than the first trimester (FT) (81.4%) and third trimester (TT) (75.9%). It is concluded that there is high
seroprevalence of HCMV among pregnant women investigated. It is hereby advocated that relevant vaccines should be made
available to protect women of child bearing age and pregnant women. |
URI: | http://hdl.handle.net/123456789/1688 |
Appears in Collections: | Medical Laboratory Sciences
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|